 progress fibrinolysi tumor necrosi factor infus human concomit increas tissue-typ plasminogen activ plasminogen activ inhibitor fibrin ogen degrad product sever investig tumor necrosi factor tnf product plasminogen activ plasminogen activ pa endotheli cell vitro vivo effect recombin human tnf administr fibrinolysi paramet plasma period continu tnf infus cancer patient activ diseas plasma level pai activ sevenfold hour tnf infus result increas antigen antigen detect plasma concentr tissue-typ PA t-pa antigen twofold hour tnf infus urokinase-typ PA antigen level plasma unalt hour tnf infus plasma level alpha averag fibrinolysi hour tnf infus signific increas fibrin- fibrinogen-degrad product fibrin degrad product fibrinogen degrad product fibrinolysi presenc high level pai activ wherea product t-pa product human endotheli cell vitro remain unalt decreas tnf addit tnf infus patient result thrombin fibrin gener possibl thrombin tnf actual stimulu t-pa product patient fibrin tnf infus plasmin t-pa action initi format solubl fibrin molecul process gener degrad product fibrin fibrinogen infus tnf patient